Sale!

ALG11 Gene Congenital disorder of glycosylation type Ip Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ALG11 gene plays a critical role in the process of glycosylation, which is the attachment of sugars to proteins and lipids, a critical process necessary for proper cellular function. Mutations in the ALG11 gene can lead to a rare condition known as Congenital Disorder of Glycosylation Type Ip (CDG-Ip), a genetic disorder that affects multiple systems of the body, including the nervous system, liver, and coagulation processes, leading to a wide range of potential symptoms such as developmental delay, liver dysfunction, and coagulation abnormalities.

To diagnose this condition, a specific genetic test targeting the ALG11 gene can be conducted. In the United Arab Emirates, DNA Labs UAE offers this specialized genetic testing service. The test is designed to identify mutations in the ALG11 gene that are responsible for CDG-Ip, providing essential information for accurate diagnosis and management of the disorder. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the comprehensive information it provides to healthcare providers, patients, and their families.

Conducting this test at DNA Labs UAE involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing technologies to detect mutations in the ALG11 gene. The results of this test can confirm a diagnosis of CDG-Ip, guide treatment decisions, and provide important information for genetic counseling of affected families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ALG11 Gene Congenital Disorder of Glycosylation Type Ip Genetic Test

Test Details

ALG11 Gene Congenital disorder of glycosylation, type Ip is a rare genetic disorder that affects the process of adding sugar molecules to proteins and lipids in the body. This disorder is caused by mutations in the ALG11 gene, which is responsible for encoding an enzyme involved in the glycosylation process.

NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It allows for the detection of genetic variations, including mutations, in a more efficient and comprehensive manner compared to traditional sequencing methods.

The ALG11 gene NGS genetic test specifically focuses on sequencing the ALG11 gene to identify any mutations or variations that may be causing the Congenital disorder of glycosylation, type Ip. This test can help diagnose individuals with this disorder, provide information about disease progression and prognosis, and aid in genetic counseling and family planning.

It is important to consult with a healthcare professional or genetic counselor to understand the specific implications and limitations of this genetic test, as well as to discuss the potential benefits and risks of undergoing such testing.

Test Name: ALG11 Gene Congenital disorder of glycosylation type Ip Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for ALG11 Gene Congenital disorder of glycosylation, type Ip NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with Congenital disorder of glycosylation, type Ip

Test Name ALG11 Gene Congenital disorder of glycosylation type Ip Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ALG11 Gene Congenital disorder of glycosylation, type Ip NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Congenital disorder of glycosylation, type Ip
Test Details

ALG11 Gene Congenital disorder of glycosylation, type Ip is a rare genetic disorder that affects the process of adding sugar molecules to proteins and lipids in the body. This disorder is caused by mutations in the ALG11 gene, which is responsible for encoding an enzyme involved in the glycosylation process.

NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It allows for the detection of genetic variations, including mutations, in a more efficient and comprehensive manner compared to traditional sequencing methods.

The ALG11 gene NGS genetic test specifically focuses on sequencing the ALG11 gene to identify any mutations or variations that may be causing the Congenital disorder of glycosylation, type Ip. This test can help diagnose individuals with this disorder, provide information about disease progression and prognosis, and aid in genetic counseling and family planning.

It is important to consult with a healthcare professional or genetic counselor to understand the specific implications and limitations of this genetic test, as well as to discuss the potential benefits and risks of undergoing such testing.